Progress towards a vaccine to prevent sexual transmission of HIV

Nature Medicine

Volumn 2, Issue 7, 1996, Pages 751-752

  Miller, Christopher J ^a   Mcghee, Jerry R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS VACCINE;

DRUG DEVELOPMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; SIMIAN IMMUNODEFICIENCY VIRUS;

AIDS VACCINES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; HAPLORHINI; HIV INFECTIONS; MUCOUS MEMBRANE; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0029984115     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0796-751     Document Type: Short Survey

References (12)

1. Marthas, M. et al. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against intravenous and intravaginal challenge, in Vaccines 1992 (ed. Brown, F., Chanock, R.M., Ginsberg, H.S. & Lerner, R.A.) 117-122 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1992).
2. Miller, C.J., Alexander, N.J., Vogel, P., Anderson, J. & Marx, P.A. Mechanism of genital transmission of SIV: A hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 21, 64-68 (1992).
3. Miller, C.J., McGhee, J.R. & Gardner, M.B. Mucosal immunity, HIV transmission and AIDS. Lab. Invest. 68, 129-145 (1992).
4. Clerici, M. et al. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 8, 1391-1395 (1994).
5. Cranage, M.P. et al. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet 339, 273-274 (1992).
6. Lehner, T. et al. Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med. 2, 767-775 (1996).
7. Thapar, M.A., Parr, E.L. & Parr, M.B. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology 70, 121-125 (1990).
8. Moore, J.P. et al. Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J. Virol. 70, 427-444 (1996).
9. Brinchmann, J.E., Gaudernack, G. & Vartdal, F. CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. J. Immunol. 144, 2961-2966 (1990).
10. Copeland, K.F.T., McKay, P.J. & Rosenthal, K.L. Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific. AIDS Res. Hum. Retrovir. 11, 1321-1326 (1995).
11. Otsyula, M.G. et al. Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251. Virology (in the press).
12. Lohman, B.L., Miller, C.J. & McChesney, M.B. Antiviral cytotoxic T lymphocytes in the vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 155, 5855-5860 (1995).